IDO1 and acute myeloid leukemia: Furthermore, leukemic cells can exacerbate T cell apoptosis and foster regulatory T cell (Treg) populations by producing indoleamine 2,3-dioxygenase 1 (IDO1), ultimately leading to diminished relapse-free and overall survival rates in AML cases12–14.